Acumen pharmaceuticals to participate in the 2024 bank of america healthcare conference

Charlottesville, va., may 08, 2024 (globe newswire) -- acumen pharmaceuticals, inc. (nasdaq: abos), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of alzheimer's disease, announced today that management will participate in a fireside chat at the 2024 bank of america healthcare conference on wednesday, may 15, 2024, at 8:55 a.m. pt (11:55 a.m. et).
ABOS Ratings Summary
ABOS Quant Ranking